Literature DB >> 8044649

Screening for carriers of cystic fibrosis among pregnant women: a pilot study.

M Schwartz1, N J Brandt, F Skovby.   

Abstract

Cystic fibrosis (CF) is one of the most common hereditary disorders among Caucasians. In such populations a highly prevalent mutation causing CF, delta F508, has been identified. It comprises 88% of Danish CF mutations. This mutation and five others account for 90% of all CF mutations, making carrier screening on a population basis worthy of consideration. We have therefore performed a pilot screening programme for CF carriers among pregnant women. From June 1, 1990, for the following 2 years, 6,599 women were tested: 172 were heterozygous for delta F508. Three of 162 partners tested were also heterozygous for delta F508. After genetic counselling all three couples at risk for having a child with CF requested prenatal diagnosis. One fetus was homozygous for delta F508, and the pregnancy was terminated. With currently available techniques, the screening programme presented here causes no practical problems, and screening for CF carriers can easily be run on a larger scale.

Entities:  

Mesh:

Year:  1993        PMID: 8044649     DOI: 10.1159/000472417

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  11 in total

1.  Cystic fibrosis carrier population screening in the primary care setting.

Authors:  S Loader; P Caldwell; A Kozyra; J C Levenkron; C D Boehm; H H Kazazian; P T Rowley
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  Newborn screening for cystic fibrosis: techniques and strategies.

Authors:  Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2007-05-12       Impact factor: 4.982

3.  Costs, effects, and savings of screening for cystic fibrosis gene carriers.

Authors:  M F Wildhagen; H B Hilderink; J G Verzijl; J B Verheij; L Kooij; T Tijmstra; L P ten Kate; J D Habbema
Journal:  J Epidemiol Community Health       Date:  1998-07       Impact factor: 3.710

4.  "Suddenly Having two Positive People who are Carriers is a Whole New Thing" - Experiences of Couples Both Identified as Carriers of Cystic Fibrosis Through a Population-Based Carrier Screening Program in Australia.

Authors:  Liane Ioannou; Martin B Delatycki; John Massie; Jan Hodgson; Sharon Lewis
Journal:  J Genet Couns       Date:  2015-05-01       Impact factor: 2.537

Review 5.  Carrier screening in the community.

Authors:  D J Brock
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population.

Authors:  U Jung; U Urner; K Grade; C Coutelle
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

7.  Cystic fibrosis heterozygote screening in 5,161 pregnant women.

Authors:  D R Witt; C Schaefer; P Hallam; S Wi; B Blumberg; A Fishbach; J Holtzman; S Kornfeld; R Lee; L Nemzer; R Palmer
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

8.  394delTT: a Nordic cystic fibrosis mutation.

Authors:  M Schwartz; M Anvret; M Claustres; H G Eiken; K Eiklid; C Schaedel; L Stolpe; L Tranebjaerg
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

9.  Diminished concentrations of insulin-like growth factor I in cystic fibrosis.

Authors:  E M Laursen; A Juul; S Lanng; N Høiby; C Koch; J Müller; N E Skakkebaek
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

10.  Prenatal screening for cystic fibrosis carriers: an economic evaluation.

Authors:  P T Rowley; S Loader; R M Kaplan
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.